Edwards Lifesciences Corporation (EW) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM EST
Company Participants
Scott Ullem – Corporate VP & CFO
Conference Call Participants
Joshua Jennings – TD Cowen, Research Division
Presentation
Joshua Jennings
TD Cowen, Research Division
We’re going to get started here as we’re moving down the medical devices company presentation, fireside chat track at the 46th Annual TD Cowen Healthcare Conference. I’m Josh Jennings from the TD Cowen Medical Devices team, and we are honored to have Edwards’ CFO, Scott Ullem, joining us making the track out from the West Coast. Scott, thanks so much for being here.
Scott Ullem
Corporate VP & CFO
That’s our pleasure, and I’m here with my colleague, Gerianne Sarte, who’s going to be taking over as Head of Investor Relations in April.
Joshua Jennings
TD Cowen, Research Division
Thank you for introducing her. I’m sorry, I didn’t introduce you, myself. I’ve got mixed emotions here at this — you’ve been the regular attendee and your team of the TD Cowen Healthcare Conference. And this may be the last time we get to have a chat up here on stage.
Scott Ullem
Corporate VP & CFO
Well, I haven’t been here for all 46 of your annual investor conferences, but it’s always a pleasure to be here. Thanks, Josh.
Question-and-Answer Session
Joshua Jennings
TD Cowen, Research Division
Thanks, Scott. And maybe to start, just maybe the succession path and the process, any updates there? I mean it seems like there has been some restructuring in the — some of the big executives at Edwards over the past couple of years with Mike Mussallem leaving, Larry Wood leaving and now you’re departing as well. But I think in each instance, the executive’s departure was — the basis was you’re leaving the company in a good position and you have a strong team